Amunix Inks $1.5 Billion+ Licensing Deal with RocheBusiness, Deals, Non-Cancer TherapiesRoche will utilize Amunix Pharmaceuticals’ XTEN technology platform to identify and develop non-cancer therapies against specific undisclosed targets. Read more January 10, 2020/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Amunix_BioSpace_584W.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2020-01-10 12:04:052020-01-13 10:12:57Amunix Inks $1.5 Billion+ Licensing Deal with Roche